Corvus Pharmaceuticals (CRVS) Capital Expenditures (2015 - 2026)
Corvus Pharmaceuticals' Capital Expenditures came in at $582,000 for Q2 2026, up 415.0% from $113,000 a year earlier and up 539.6% from the prior quarter.
Powered by 
Analysis
Corvus Pharmaceuticals (CRVS) Capital Expenditures (2015 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Corvus Pharmaceuticals reported Capital Expenditures of $698,000, up 368.5% year-over-year; for FY2025, it came in at $174,000.
- Capital Expenditures carries a five-year compound annual growth rate of 18.0% (FY2020 to FY2025).
- Going back by year, Capital Expenditures was $34,000 in FY2023 (-87.4%), $269,000 in FY2022 and $5,000 in FY2021 (-93.4%).
- The Q2 2026 figure represents the highest quarterly Capital Expenditures since Q4 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Corvus Pharmaceuticals | 989.26 Mn | 477.70 Mn | - | 582,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 582,000.00 |
| Mar 31, 2026 | 91,000.00 |
| Dec 31, 2025 | 25,000.00 |
| Jun 30, 2025 | 113,000.00 |
| Mar 31, 2025 | 36,000.00 |
| Mar 31, 2023 | 34,000.00 |
| Sep 30, 2022 | 265,000.00 |
| Dec 31, 2019 | 5,000.00 |
| Sep 30, 2019 | 4,000.00 |
| Mar 31, 2019 | 16,000.00 |
| Dec 31, 2018 | 135,000.00 |
| Sep 30, 2018 | 160,000.00 |
| Jun 30, 2018 | 54,000.00 |
| Mar 31, 2018 | 6,000.00 |
| Dec 31, 2017 | -8,000.00 |
| Sep 30, 2017 | 42,000.00 |
| Jun 30, 2017 | 121,000.00 |
| Mar 31, 2017 | 111,000.00 |
| Dec 31, 2016 | 613,000.00 |
| Sep 30, 2016 | 99,000.00 |
API Access
Corvus Pharmaceuticals Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CRVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "CRVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CRVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();